| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.55 | 0.05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |